FABIO PUCCI

Fabio Pucci is a distinguished investor at Leaps by Bayer, the strategic impact investment unit of the global life science company Bayer. In his pivotal role, Fabio is instrumental in identifying, evaluating, and nurturing early to growth stage companies that are poised to deliver transformative solutions in critical sectors. His work aligns directly with Leaps by Bayer's mission to invest in breakthrough innovations that have the potential to overcome some of humanity's biggest challenges, ranging from curing intractable diseases to ensuring sustainable food security.

At Leaps by Bayer, Fabio Pucci's investment focus spans a broad spectrum of life sciences, healthcare, and agriculture. This includes cutting-edge areas such as novel therapeutics, gene and cell therapies, digital health platforms, sustainable agriculture technologies, and advanced biotechnologies. He seeks out ventures that demonstrate robust scientific foundations, clear market potential, and a strong commitment to creating a positive societal impact. Fabio's approach involves a deep dive into the scientific merits and business models of potential portfolio companies, ensuring that investments are strategically sound and aligned with Leaps by Bayer's long-term vision.

Fabio's career background reflects a strong blend of scientific acumen and financial expertise, making him uniquely suited for his role in venture capital within the life sciences. Prior to joining Leaps by Bayer, he honed his skills through various roles in corporate development and strategic finance within the pharmaceutical and biotech industries. This experience provided him with an intricate understanding of the challenges and opportunities inherent in bringing innovative scientific discoveries from the lab to market. His earlier career also included foundational work in financial analysis and investment banking, equipping him with a comprehensive toolkit for evaluating complex investment opportunities.

While specific notable investments are often confidential, Fabio Pucci has been involved in supporting a portfolio of companies that are developing pioneering solutions. These include firms working on next-generation cancer therapies, sustainable crop protection methods, and AI-driven diagnostic tools. His contributions extend beyond capital allocation, often involving active engagement with portfolio companies to provide strategic guidance, facilitate partnerships, and support their growth trajectories. Fabio's dedication to fostering innovation underscores Leaps by Bayer's commitment to building a healthier and more sustainable future through strategic impact investing.